259 related articles for article (PubMed ID: 21224835)
1. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.
Millington-Ward S; Chadderton N; O'Reilly M; Palfi A; Goldmann T; Kilty C; Humphries M; Wolfrum U; Bennett J; Humphries P; Kenna PF; Farrar GJ
Mol Ther; 2011 Apr; 19(4):642-9. PubMed ID: 21224835
[TBL] [Abstract][Full Text] [Related]
2. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
[TBL] [Abstract][Full Text] [Related]
3. Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.
Chadderton N; Millington-Ward S; Palfi A; O'Reilly M; Tuohy G; Humphries MM; Li T; Humphries P; Kenna PF; Farrar GJ
Mol Ther; 2009 Apr; 17(4):593-9. PubMed ID: 19174761
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated suppression and replacement of human rhodopsin in vivo.
O'Reilly M; Palfi A; Chadderton N; Millington-Ward S; Ader M; Cronin T; Tuohy T; Auricchio A; Hildinger M; Tivnan A; McNally N; Humphries MM; Kiang AS; Humphries P; Kenna PF; Farrar GJ
Am J Hum Genet; 2007 Jul; 81(1):127-35. PubMed ID: 17564969
[TBL] [Abstract][Full Text] [Related]
5. Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP).
Ahmed CM; Massengill MT; Ildefonso CJ; Jalligampala A; Zhu P; Li H; Patel AP; McCall MA; Lewin AS
Vision Res; 2023 May; 206():108189. PubMed ID: 36773475
[TBL] [Abstract][Full Text] [Related]
6. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
[TBL] [Abstract][Full Text] [Related]
7. Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa.
Greenwald DL; Cashman SM; Kumar-Singh R
Gene Ther; 2013 Apr; 20(4):425-34. PubMed ID: 22809998
[TBL] [Abstract][Full Text] [Related]
8. Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.
Cideciyan AV; Sudharsan R; Dufour VL; Massengill MT; Iwabe S; Swider M; Lisi B; Sumaroka A; Marinho LF; Appelbaum T; Rossmiller B; Hauswirth WW; Jacobson SG; Lewin AS; Aguirre GD; Beltran WA
Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8547-E8556. PubMed ID: 30127005
[TBL] [Abstract][Full Text] [Related]
9. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE
Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638
[TBL] [Abstract][Full Text] [Related]
10. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
11. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
Orlans HO; Barnard AR; PatrÃcio MI; McClements ME; MacLaren RE
Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
[TBL] [Abstract][Full Text] [Related]
12. Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa.
Tsai YT; Wu WH; Lee TT; Wu WP; Xu CL; Park KS; Cui X; Justus S; Lin CS; Jauregui R; Su PY; Tsang SH
Ophthalmology; 2018 Sep; 125(9):1421-1430. PubMed ID: 29759820
[TBL] [Abstract][Full Text] [Related]
13. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach.
Gorbatyuk MS; Pang JJ; Thomas J; Hauswirth WW; Lewin AS
Mol Vis; 2005 Aug; 11():648-56. PubMed ID: 16145542
[TBL] [Abstract][Full Text] [Related]
15. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa.
Mussolino C; Sanges D; Marrocco E; Bonetti C; Di Vicino U; Marigo V; Auricchio A; Meroni G; Surace EM
EMBO Mol Med; 2011 Mar; 3(3):118-28. PubMed ID: 21268285
[TBL] [Abstract][Full Text] [Related]
16. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Sun X; Liang C; Chen Y; Cui T; Han J; Dai M; Zhang Y; Zhou Q; Li W
Hum Gene Ther; 2024 Mar; 35(5-6):151-162. PubMed ID: 38368562
[TBL] [Abstract][Full Text] [Related]
17. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
Mitra RN; Zheng M; Weiss ER; Han Z
Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller B; Mao H; Lewin AS
Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
[TBL] [Abstract][Full Text] [Related]
19. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa.
Petersen-Jones SM; Occelli LM; Biel M; Michalakis S
Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596
[TBL] [Abstract][Full Text] [Related]
20. Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme.
Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
Exp Eye Res; 2007 Jan; 84(1):44-52. PubMed ID: 17083931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]